Comparative Pharmacology
Head-to-head clinical analysis: HALOPERIDOL LACTATE versus THIOTHIXENE HYDROCHLORIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HALOPERIDOL LACTATE versus THIOTHIXENE HYDROCHLORIDE.
HALOPERIDOL LACTATE vs THIOTHIXENE HYDROCHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Haloperidol lactate is a typical antipsychotic that exerts its effects primarily by blocking dopamine D2 receptors in the brain, particularly in the mesolimbic and mesocortical pathways. It also has antagonistic activity at alpha-1 adrenergic receptors and limited affinity for serotonin receptors.
Thiothixene hydrochloride is a typical antipsychotic that blocks postsynaptic dopamine D2 receptors in the central nervous system (CNS), particularly in the mesolimbic and mesocortical pathways. It also has alpha-adrenergic blocking activity and weak anticholinergic effects.
2-5 mg intramuscularly or intravenously every 4-8 hours for acute agitation. Maximum 20 mg/day.
Initial: 2-5 mg orally 3 times daily; maintenance: 15-30 mg orally per day in divided doses; maximum: 60 mg orally per day.
None Documented
None Documented
14–26 hours (terminal elimination half-life); may be prolonged in hepatic impairment or with repeated dosing due to accumulation.
Terminal elimination half-life: 34 hours (range 25–50 hrs) in adults; clinical context: allows once-daily dosing.
Renal (approximately 40% as metabolites, <1% as unchanged drug); fecal (approximately 15%); remainder metabolized with unknown fate.
Renal: primarily as metabolites, <1% unchanged; fecal: minor; biliary: some metabolites excreted in bile.
Category A/B
Category C
Typical Antipsychotic
Typical Antipsychotic